Wordt geladen...
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
INTRODUCTION: Interstitial lung disease (ILD) is a frequent extra-articular manifestation of Rheumatoid arthritis (RA), but nowadays there are no randomized controlled clinical trials to support therapeutic guidelines. RA-ILD, especially with UIP pattern, shares some similarities with idiopathic pul...
Bewaard in:
| Gepubliceerd in: | Respir Med Case Rep |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7150508/ https://ncbi.nlm.nih.gov/pubmed/32292694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101051 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|